Skip to main content

Polymer Nanoparticles for Release of Rifampicin

Buy Article:

$107.14 + tax (Refund Policy)

Gelatin-hydroxyethyl cellulose nanoparticles were prepared using reverse emulsion w/o method. Crosslinking was carried out with glutaric aldehyde within aqueous droplets containing polymers mixture, dispersed into toluene in presence of surfactants. Various formulations were prepared by varying the ratio of gelatin and hydroxyethyl cellulose, the concentration of polymers solution and the ratio of polymers mixture and glutaric aldehyde. The influence of those parameters on the composition, size, size dispersity, particle swelling and their ability for drug inclusion and release was studied. The particles size range of nanoparticles was between 200–700 nm. The ability to take-up drugs and the size are directly correlated with the degree of swelling and gelatin content within the nanoparticles. In vitro rifampicin loading/release from nanoparticles was studied. The very low toxicity, the hemocompatibility and biodegradability of these nanoparticles makes them potential drug carriers.

Keywords: GELATIN; HYDROXYETHYL CELLULOSE; POLYMER NANOPARTICLES; RIFAMPICIN RELEASE

Document Type: Research Article

Publication date: 01 February 2013

More about this publication?
  • Advanced Science, Engineering and Medicine (ASEM) is a science, engineering, technical and medical journal focused on the publishing of peer-reviewed multi-disciplinary research articles dealing with all fundamental and applied research aspects in the areas of (1) Physical Sciences, (2) Engineering, (3) Biological Sciences/Health Sciences, (4) Medicine, (5) Computer and Information Sciences, (6) Mathematical Sciences, (7) Agriculture Science and Engineering, (8) Geosciences, and (9) Energy/Fuels/Environmental/Green Science and Engineering.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content